Access Consortium statement on Good Manufacturing Practice inspections reliance and recognition evidence

Access Consortium statement on Good Manufacturing Practice inspections reliance and recognition evidence The Access Heads of Agencies have issued a collective statement that aligns with the Consortium’s strategic objective to expand and maximize collaboration through the life cycle of a product and solidifies the Consortium’s commitment to demonstrate greater inspection reliance and accept GMP inspection outcomes. 2023-02-27 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyAccess Consortium statementConsortium’s strategic objectiveConsortium’s commitmentGood Manufacturing PracticeGMP inspection outcomesinspections reliancerecognition Access Consortium statement on Good Manufacturing Practice inspections reliance and recognition evidenceHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/access-statement-gmp-inspections-reliance-recognitions-evidence.html Access Consortium statement on Good Manufacturing Practice inspections reliance and recognition evidenceHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/conformite-application-loi/bonnes-pratiques-fabrication/declaration-access-fiabilite-reconnaissance-inspections-bpf.html

The Access Heads of Agencies have issued a collective statement that aligns with the Consortium’s strategic objective to expand and maximize collaboration through the life cycle of a product and solidifies the Consortium’s commitment to demonstrate greater inspection reliance and accept GMP inspection outcomes.

Data and Resources

Similar records